DOPAMINE RECEPTOR SUBTYPE IMBALANCE IN SCHIZOPHRENIA

[1] EVIDENCE FOR DIFFERENT STATES OF THE DOPAMINE D1 RECEPTOR - CLOZAPINE AND FLUPERLAPINE MAY PREFERENTIALLY LABEL AN ADENYLATE CYCLASE-COUPLED STATE OF THE D1-RECEPTOR [J]. JOURNAL OF NEUROCHEMISTRY, 1986, 47 (06) : 1822 - 1831

[2] ANDERSEN PH, 1986, NEUROBIOLOGY CENTRAL, P73

[3] DIFFERENTIAL INVOLVEMENT OF DOPAMINE D-1 AND D-2 RECEPTORS IN THE CIRCLING BEHAVIOR INDUCED BY APOMORPHINE, SK+F-38393, PERGOLIDE AND LY-171555 IN 6-HYDROXYDOPAMINE-LESIONED RATS [J]. PSYCHOPHARMACOLOGY, 1985, 85 (03) : 346 - 352

[4] DOPAMINE AND THE PATHO-PHYSIOLOGY OF DYSKINESIAS INDUCED BY ANTIPSYCHOTIC-DRUGS [J]. ANNUAL REVIEW OF NEUROSCIENCE, 1980, 3 : 23 - 41

[5] DOPAMINERGIC MECHANISMS AND MOTOR FUNCTION - CHARACTERIZATION OF D-1 AND D-2 DOPAMINE RECEPTOR INTERACTIONS [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 123 (01) : 109 - 114

[6] CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM [J]. LIFE SCIENCES, 1984, 35 (18) : 1885 - 1893

[7] SCH-23390 ANTAGONISM OF A D-2 DOPAMINE AGONIST DEPENDS UPON CATECHOLAMINERGIC NEURONS [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 113 (01) : 109 - 114

[8] BREESE GR, 1986, NEUROBIOLOGY CENTRAL

[9] ANTI-SCHIZOPHRENIC DRUGS - CHRONIC TREATMENT ELEVATES DOPAMINE RECEPTOR-BINDING IN BRAIN [J]. SCIENCE, 1977, 196 (4287) : 327 - 328

[10] CARENZI A, 1975, ARCH GEN PSYCHIAT, V32, P1056

[1] EVIDENCE FOR DIFFERENT STATES OF THE DOPAMINE D1 RECEPTOR - CLOZAPINE AND FLUPERLAPINE MAY PREFERENTIALLY LABEL AN ADENYLATE CYCLASE-COUPLED STATE OF THE D1-RECEPTOR [J]. JOURNAL OF NEUROCHEMISTRY, 1986, 47 (06) : 1822 - 1831

[2] ANDERSEN PH, 1986, NEUROBIOLOGY CENTRAL, P73

[3] DIFFERENTIAL INVOLVEMENT OF DOPAMINE D-1 AND D-2 RECEPTORS IN THE CIRCLING BEHAVIOR INDUCED BY APOMORPHINE, SK+F-38393, PERGOLIDE AND LY-171555 IN 6-HYDROXYDOPAMINE-LESIONED RATS [J]. PSYCHOPHARMACOLOGY, 1985, 85 (03) : 346 - 352

[4] DOPAMINE AND THE PATHO-PHYSIOLOGY OF DYSKINESIAS INDUCED BY ANTIPSYCHOTIC-DRUGS [J]. ANNUAL REVIEW OF NEUROSCIENCE, 1980, 3 : 23 - 41

[5] DOPAMINERGIC MECHANISMS AND MOTOR FUNCTION - CHARACTERIZATION OF D-1 AND D-2 DOPAMINE RECEPTOR INTERACTIONS [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 123 (01) : 109 - 114

[6] CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM [J]. LIFE SCIENCES, 1984, 35 (18) : 1885 - 1893

[7] SCH-23390 ANTAGONISM OF A D-2 DOPAMINE AGONIST DEPENDS UPON CATECHOLAMINERGIC NEURONS [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 113 (01) : 109 - 114

[8] BREESE GR, 1986, NEUROBIOLOGY CENTRAL

[9] ANTI-SCHIZOPHRENIC DRUGS - CHRONIC TREATMENT ELEVATES DOPAMINE RECEPTOR-BINDING IN BRAIN [J]. SCIENCE, 1977, 196 (4287) : 327 - 328

[10] CARENZI A, 1975, ARCH GEN PSYCHIAT, V32, P1056